Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathway.
about
CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption.Qian Five Rhinoceros Gindeng (QFRG) protects against development of immune thrombocytopenia via miR-181a inhibition of TLR-4 expressionThe Role of CD44 in Disease Pathophysiology and Targeted Treatment.
P2860
Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathway.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Amelioration of murine passive ...... e the Myd88 signaling pathway.
@ast
Amelioration of murine passive ...... e the Myd88 signaling pathway.
@en
type
label
Amelioration of murine passive ...... e the Myd88 signaling pathway.
@ast
Amelioration of murine passive ...... e the Myd88 signaling pathway.
@en
prefLabel
Amelioration of murine passive ...... e the Myd88 signaling pathway.
@ast
Amelioration of murine passive ...... e the Myd88 signaling pathway.
@en
P2860
P1433
P1476
Amelioration of murine passive ...... e the Myd88 signaling pathway.
@en
P2093
Dongji Han
Honghui Yu
P2860
P304
P356
10.1371/JOURNAL.PONE.0071882
P407
P577
2013-08-05T00:00:00Z